#Shingles #vaccines show promise against herpes zoster in patients with #cancer via
"Although implementation plans have yet to be finalized, some countries such as the U.K. are likely to recommend the recombinant herpes zoster #vaccine for patients who are immunocompromised and aged 50 years or older in the coming months.”